The FDA has placed an Investigational Drug For Sickle Cell Disease on Clinical Hold
geralt / Pixabay

The FDA has placed an Investigational Drug For Sickle Cell Disease on Clinical Hold

The Investigational New Drug Application for the experimental drug CTX001 for treating sickle cell disease has been put on clinical hold, announced Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics. This hold…

Continue Reading The FDA has placed an Investigational Drug For Sickle Cell Disease on Clinical Hold
Gene Therapy Could Put an End to Blood Transfusions for Beta Thalessemia Patients
JuralMin / Pixabay

Gene Therapy Could Put an End to Blood Transfusions for Beta Thalessemia Patients

According to a story from empr.com, a recent study revealed that gene therapy could allow patients with beta thalessemia to stop having to get regular blood transfusions. The gene therapy…

Continue Reading Gene Therapy Could Put an End to Blood Transfusions for Beta Thalessemia Patients

Updated Results From Cancer Drug Trial Show Greater Improvements Than Previously Reported

According to a story from Reuters, the cancer drug developer Loxo Oncology recently released the latest results from the trial testing its investigational therapy LOXO-292. Preliminary results released about a…

Continue Reading Updated Results From Cancer Drug Trial Show Greater Improvements Than Previously Reported
Artificial Intelligence Shows Hope With GPI Deficiency And Mabry Diagnosis
Source: Pixabay

Artificial Intelligence Shows Hope With GPI Deficiency And Mabry Diagnosis

Researchers from the University Hospital Bonn in Berlin, Germany have successfully used artificial intelligence image scanning to diagnose patients with Glycolipid (GPI) anchor deficiencies, reports Healthcare Analytics News. They recently published…

Continue Reading Artificial Intelligence Shows Hope With GPI Deficiency And Mabry Diagnosis
A Report on UK Patients with Primary Immunodeficiency Hopes to Inform Medical Professionals About the Conditions
kreatikar / Pixabay

A Report on UK Patients with Primary Immunodeficiency Hopes to Inform Medical Professionals About the Conditions

A primary immunodeficiency report, published in the journal Clinical and Experimental Immunology, examines medical care for primary immunodeficiency patients in the UK. The publication of the report coincides with the…

Continue Reading A Report on UK Patients with Primary Immunodeficiency Hopes to Inform Medical Professionals About the Conditions
Research Suggests a Multiple Sclerosis Treatment May Also Benefit Mucolipidosis IV
Source: Pixabay

Research Suggests a Multiple Sclerosis Treatment May Also Benefit Mucolipidosis IV

Researchers at the Massachusetts General Hospital Research Institute and the Georgia Institute of Technology are investigating a medication currently approved to treat a type of multiple sclerosis as a possible…

Continue Reading Research Suggests a Multiple Sclerosis Treatment May Also Benefit Mucolipidosis IV
The State of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Research in 2018
Source: Pixabay

The State of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Research in 2018

Myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) has been a controversial condition ever since it was first diagnosed and recognized. Some uninformed doctors still believe that the syndrome is a psychological…

Continue Reading The State of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Research in 2018

Scientists Have Identified Genes Involved in Hereditary Angioedema Acute Attacks

Researchers have carried out a study into the genetic mechanisms involved in hereditary angioedema acute attacks. They found that two genes, called uPAR and ADM, had a particularly strong influence.…

Continue Reading Scientists Have Identified Genes Involved in Hereditary Angioedema Acute Attacks
Research Shows That a Facial Cream Containing Rapamycin Could Improve Facial Tumours Linked to Tuberous Sclerosis Complex
Source: Pixabay

Research Shows That a Facial Cream Containing Rapamycin Could Improve Facial Tumours Linked to Tuberous Sclerosis Complex

Research into possible facial creams containing the medicine rapamycin have found that they are effective for reducing facial tumours in people with tuberous sclerosis complex. The full article can be…

Continue Reading Research Shows That a Facial Cream Containing Rapamycin Could Improve Facial Tumours Linked to Tuberous Sclerosis Complex